%0 Journal Article
%1 Liedert2007
%A Liedert, B
%A Bassus, S
%A Schneider, C K
%A Kalinke, U
%A Lower, J
%D 2007
%E Ther, Int J Clin Pharmacol
%J Int J Clin Pharmacol Ther
%K kalinke
%N 1
%P 1-9
%T Safety of phase I clinical trials with monoclonal antibodies in Germany--the regulatory requirements viewed in the aftermath of the TGN1412 disaster
%U http://www.ncbi.nlm.nih.gov/pubmed/17256444
%V 45